3692:HKG
Hansoh Pharmaceutical Group Company Ltd
HK$32.72
arrow_downward
-1.86%(-0.62) 1D
Sep 11, 4:08:54 PM GMT+8 · HKD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 3692...
Open
HK$33.32
High
HK$33.52
Low
HK$32.28
Mkt. cap
198.42B
Avg. vol.
0.00
Volume
13.16M
Dividend
1.48%
Quarterly dividend
HK$0.12
Ex-dividend date
Jul 3, 2026
P/E ratio
25.36
52-wk high
HK$44.22
52-wk low
HK$28.06
EPS
HK$1.29
No. of employees
10K
Open
HK$33.32
High
HK$33.52
Low
HK$32.28
Mkt. cap
198.42B
Avg. vol.
0.00
Volume
13.16M
Dividend
1.48%
Quarterly dividend
HK$0.12
Ex-dividend date
Jul 3, 2026
P/E ratio
25.36
52-wk high
HK$44.22
52-wk low
HK$28.06
EPS
HK$1.29
No. of employees
10K
News stories
From web sources and news partners
TipRanks
·
1 day ago
Hansoh’s Lung Cancer Drug HS-20093 Wins NMPA Priority Review
Profile
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company that manufactures and sells various types of medicine in mainland China. It was founded in 1995 in Lianyungang, Jiangsu Province, China, by Zhong Huijuan, who is the company's chair. Zhong and her family own 66% of the company. It is the largest psychotropic drug producer in China.
Hansoh Pharmaceutical had an initial public offering on the main board of the Hong Kong Stock Exchange on 14 June 2019.
In August 2022, it was announced that the company's stock would be added to the Hang Seng Index. Wikipedia
About Hansoh Pharmaceutical Group Company Ltd